roflumilast
SpainDrugs containing this active substance
-
It is used for the maintenance treatment of severe chronic obstructive pulmonary disease (COPD) in adults who have chronic bronchitis and have suffered frequent worsening of their symptoms. It should be used in conjunction with bronchodilators.
Form: tablets
Active substance Dosage roflumilast 250 µg Manufacturer: Astrazeneca Ab
-
It is used for the maintenance treatment of severe chronic obstructive pulmonary disease (COPD) in adults who have chronic bronchitis and have suffered frequent exacerbations of their symptoms.
Form: tablets, film-coated
Active substance Dosage roflumilast 500 µg Manufacturer: Astrazeneca Ab
-
It is used for the maintenance treatment of severe chronic obstructive pulmonary disease (COPD) in adults who have chronic bronchitis and who have suffered frequent exacerbations of their symptoms.
Form: tablets
Active substance Dosage roflumilast 0,25 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used for the maintenance treatment of severe chronic obstructive pulmonary disease (COPD) in adults who have chronic bronchitis and who have suffered frequent exacerbations of their symptoms. It should be used in conjunction with bronchodilators.
Form: tablets
Active substance Dosage roflumilast 0,5 mg Manufacturer: Aurovitas Spain, S.A.U.